The global post-marketing pharmacovigilance and medical information market size reached US$ 5.6 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 13.0 Billion by 2032, exhibiting a growth rate (CAGR) of 9.81% during 2023-2032.
Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications.
Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.
Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.
2. What is the expected growth rate of the global post-marketing pharmacovigilance and medical information market during 2024-2032?
3. What are the key factors driving the global post-marketing pharmacovigilance and medical information market?
4. What has been the impact of COVID-19 on the global post-marketing pharmacovigilance and medical information market?
5. What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the type?
6. What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the end user?
7. What are the key regions in the global post-marketing pharmacovigilance and medical information market?
8. Who are the key players/companies in the global post-marketing pharmacovigilance and medical information market?
Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications.
Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.
Post-marketing Pharmacovigilance and Medical Information Market Trends:
The growing global geriatric population and the rising occurrence of various chronic medical disorders, such as diabetes, hypertension, dementia, cardiovascular diseases, and osteoporosis, represent one of the key factors increasing the consumption of medicines. In addition, the increasing frequency of lifestyle, respiratory and cardiovascular infections, and neurological and oncological diseases are resulting in the increasing sales of drugs worldwide. This, in turn, is creating a positive market outlook. In line with this, the rising prevalence of Adverse Drug Reactions (ADRs), coupled with the incorporation of advanced ADR reporting tools, is supporting the market growth.Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global post-marketing pharmacovigilance and medical information market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product and end user.Breakup by Type:
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
Breakup by Product:
- Books
- Online Media
- Journals
Breakup by End User:
- Hospitals
- Research Organization
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd.Key Questions Answered in This Report
1. How big is the global post-marketing pharmacovigilance and medical information market?2. What is the expected growth rate of the global post-marketing pharmacovigilance and medical information market during 2024-2032?
3. What are the key factors driving the global post-marketing pharmacovigilance and medical information market?
4. What has been the impact of COVID-19 on the global post-marketing pharmacovigilance and medical information market?
5. What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the type?
6. What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the end user?
7. What are the key regions in the global post-marketing pharmacovigilance and medical information market?
8. Who are the key players/companies in the global post-marketing pharmacovigilance and medical information market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Post-marketing Pharmacovigilance and Medical Information Market
6 Market Breakup by Type
7 Market Breakup by Product
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Accenture Plc.
- ArisGlobal
- Cognizant Technology Solutions Corporation
- Ergomed Plc
- F. Hoffmann-La Roche Ltd.
- Icon Plc
- Parexel International Corporation
- Pharmaceutical Product Development Inc.
- Wipro Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 136 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 5.6 Billion |
| Forecasted Market Value ( USD | $ 13 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
